Carolin (Solution) Instructions for Use
Marketing Authorization Holder
Roscarpharm, CJSC (Russia)
ATC Code
A11CA02 (Betacarotene)
Active Substance
Betacarotene (Rec.INN registered by WHO)
Dosage Form
| Carolin | Oral and external solution 1 mg/1 ml: fl. 30 ml, 50 ml or 100 ml |
Dosage Form, Packaging, and Composition
| Oral and external solution | 1 ml |
| Betacarotene | 1 mg |
30 ml – dark glass bottles (1) – cardboard packs.
50 ml – dark glass bottles (1) – cardboard packs.
100 ml – dark glass bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Vitamin preparation
Pharmacotherapeutic Group
Vitamin
Pharmacological Action
A carotenoid, a precursor of vitamin A. It has an antioxidant effect and has the ability to inactivate free radicals under hypoxic conditions.
It protects the skin from the harmful effects of ultraviolet rays and has an antixerophthalmic effect.
Betacarotene has an immunomodulatory effect, apparently by stimulating the differentiation of B- and T-lymphocytes.
It participates in the processes of regeneration of epithelial tissues and increases their resistance to infections.
Pharmacokinetics
Absorption when taken orally is rapid and complete.
It is metabolized in the liver to form active forms of vitamin A, which bind to the retinol-transporting protein and are delivered to various organs and tissues. In the presence of Zn2+, inactive products are formed in the liver.
It is excreted by the kidneys and with bile.
Indications
Prevention and treatment of vitamin A deficiency.
To increase the body’s nonspecific resistance during exposure to low doses of radiation, X-ray examination, during radiation and chemotherapy in oncology, laser therapy, immunodeficiency states, contact with pesticides.
Age-related macular degeneration.
As part of complex therapy: gastric and duodenal ulcers, erosive gastritis, duodenitis, ulcerative colitis, dysbiosis; nonspecific diseases of the lungs and upper respiratory tract; wounds, burns, frostbite, trophic ulcers; polymorphic photodermatosis, vitiligo, local skin pigmentation, hyperpigmentation.
ICD codes
| ICD-10 code | Indication |
| D84.9 | Immunodeficiency, unspecified |
| E50 | Vitamin A deficiency |
| H53.9 | Visual disturbance, unspecified |
| J42 | Unspecified chronic bronchitis |
| J43 | Emphysema |
| J45 | Asthma |
| J47 | Bronchiectasis |
| K25 | Gastric ulcer |
| K26 | Duodenal ulcer |
| K29.7 | Unspecified gastritis |
| K29.8 | Duodenitis |
| K50 | Crohn's disease [regional enteritis] |
| K51 | Ulcerative colitis |
| L80 | Vitiligo |
| L81.9 | Disorder of pigmentation, unspecified |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| T33 | Superficial frostbite |
| Y84.2 | Radiological procedure and radiotherapy |
| ICD-11 code | Indication |
| 4A0Z | Unspecified primary immunodeficiencies |
| 5B55.Z | Vitamin A deficiency, unspecified |
| 9D7Z | Visual impairment, unspecified |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA21.Z | Emphysema, unspecified |
| CA23 | Asthma |
| CA24 | Bronchiectasis |
| DA42.Z | Gastritis, unspecified |
| DA51.Z | Duodenitis, unspecified |
| DA60.Z | Gastric ulcer, unspecified |
| DA63.Z | Duodenal ulcer, unspecified |
| DD70.Z | Crohn's disease, unspecified location |
| DD71.Z | Ulcerative colitis, unspecified |
| ED63.0 | Vitiligo |
| EK5Y | Other specified skin lesions provoked by exposure to external factors |
| ME60.1 | Pigmented lesion of skin of uncertain nature |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
| NE40 | Superficial frostbite |
| PK81.C | Radiotherapy causing injury or harm in the course of therapeutic use |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally or apply externally. Determine the dose and duration individually based on the clinical indication and patient condition.
For oral administration, use the provided graduated dropper. Take the solution during or immediately after a meal to enhance absorption.
For adults and children over 12 years, the typical prophylactic dose is 1-2 mg (1-2 ml) once daily. For therapeutic purposes, increase the dose to 4-6 mg (4-6 ml) once daily or as a divided dose.
For children aged 7 to 12 years, administer 1-2 mg (1-2 ml) once daily. For children aged 3 to 6 years, administer 1 mg (1 ml) once daily. Do not administer to children under 3 years of age without medical supervision.
For external use in treating wounds, burns, or trophic ulcers, apply the solution directly to cleansed affected areas 1-2 times daily. Apply a thin layer and cover with a sterile dressing if indicated.
For conditions like vitiligo or photodermatosis, combine oral administration with topical application to depigmented or affected skin areas as directed.
The maximum daily oral dose for adults should not exceed 10 mg (10 ml). The duration of treatment is determined by the therapeutic response; prolonged courses may be necessary for chronic conditions.
Monitor for yellow discoloration of the skin (carotenoderma), which is a dose-related and reversible effect. Discontinue use if severe or adverse reactions occur.
Adverse Reactions
Possible yellow coloration of the skin, constipation.
Rarely arthralgia.
Contraindications
Hypersensitivity to vitamin A.
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding with caution, under medical supervision.
Pediatric Use
It is possible to use in children according to indications in age-appropriate recommended doses.
Special Precautions
Betacarotene is used as a colorant in the food industry.
Drug Interactions
Calcium preparations, cholestyramine, mineral oils, neomycin, tocopherol (vitamin E) reduce the absorption of betacarotene.
Storage Conditions
Store at 2°C (36°F) to 8°C (46°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
No-spa pills 40mg, 64pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Cortexin, 10mg, 5ml, 10pcs
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
Ingavirin capsules 90mg, 10pcs
Actovegin pills 200mg, 50pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Arbidol, capsules 100mg, 40pcs
Nootropil pills 800mg, 30pcs
Picamilon pills 50mg, 60pcs
Belosalic, lotion solution for external use spray 100ml
Kagocel pills 12mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Phenibut-Vertex pills 250mg, 20pcs
Daivobet, ointment, 30g 